We are live on ! Find out more
CPX

Canaan Partners XI Portfolio holdings

AUM $127M
1-Year Est. Return 217.49%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
10 Year Est. Return
AUM
$90.7M
AUM Growth
+$10.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.97%
2 Technology 16.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYRA icon
1
Tyra Biosciences
TYRA
$1.9B
$72.3M 79.77%
4,409,991
AEVA
2
Aeva Technologies
AEVA
$1.2B
$14.5M 16.03%
3,697,039
RLYB icon
3
Rallybio
RLYB
$84.5M
$3.81M 4.2%
257,464

Similar funds

Canaan Partners XI's Q1 2024 Portfolio in Review

As of Q1 2024, Canaan Partners XI held 3 positions worth $90.7M, up 13% from $80M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Canaan Partners XI opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Technology.

  • Canaan Partners XI's ten largest holdings make up 100% of its $90.7M portfolio in Q1 2024.
  • Canaan Partners XI opened 0 new positions and closed 0 in Q1 2024.
  • Canaan Partners XI's portfolio value rose 13% quarter-over-quarter to $90.7M.

Based on Canaan Partners XI's 13F filing for Q1 2024, filed 5 Apr 2024.